Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Research and Clinical Oncology
Published in: Journal of Cancer Research and Clinical Oncology 12/2016

01-12-2016 | Review – Cancer Research

Human papillomavirus and lung cancinogenesis: an overview

Authors: Antonio Carlos de Freitas, Ana Pavla Gurgel, Elyda Golçalves de Lima, Bianca de França São Marcos, Carolina Maria Medeiros do Amaral

Published in: Journal of Cancer Research and Clinical Oncology | Issue 12/2016

Login to get access

Abstract

Lung cancer is the most common cause of cancer deaths worldwide. Although tobacco smoking is considered to be the main risk factor and the most well-established risk factor for lung cancer, a number of patients who do not smoke have developed this disease. This number varies between 15 % to over one-half of lung cancer cases, and the deaths from lung cancer in non-smokers are increasing every year. There are many other agents that are thought to be etiological, including diesel exhaust exposure, metals, radiation, radon, hormonal factors, cooking oil, air pollution and infectious diseases, such as human papillomavirus (HPV). Studies in various parts of the world have detected HPV DNA at different rates in lung tumors. However, the role of HPV in lung cancer is still unclear. Thus, in this review, we investigated some molecular mechanisms of HPV protein activity in host cells, the entry of HPV into lung tissue and the possible route used by the virus to reach the lung cells.
Literature
Aguayo F, Castillo A, Koriyama C, Higashi M, Itoh T, Capetillo M, Shuyama K, Corvalan A, Eizuru Y, Akiba S (2007) Human papillomavirus-16 is integrated in lung carcinomas: a study in Chile. Br J Cancer 97:85–91PubMedPubMedCentralCrossRef
Aguayo F, Anwar M, Koriyama C, Castillo A, Sun Q, Morewaya J, Eizuru Y, Akiba S (2010) Human papillomavirus-16 presence and physical status in lung carcinomas from Asia. Infect Agent Cancer 5:20PubMedPubMedCentralCrossRef
Aguayo F, Khan N, Koriyama C, González C, Ampuero S, Padilla O, Solís L, Eizuru Y, Corvalán A, Akiba S (2011) Human papillomavirus and Epstein-Barr virus infections in breast cancer from chile. Infect Agent Cancer 6:7PubMedPubMedCentralCrossRef
Amabile JC, Leuraud K, Vacquier B, Alain A, Dominique L (2009) Multifactorial study of the risk of lung cancer among French uranium miners: radon, smoking and silicosis. Health Phys 97(6):613–621PubMedCrossRef
Baba M, Castillo A, Koriyama C, Yanagi M, Matsumoto H, Natsugoe S, Shuyama KY, Khan N, Higashi M, Itoh T et al (2010) Human papillomavirus is frequently detected in gefitinib-responsive lung adenocarcinomas. Oncol Rep 23(4):1085–1092PubMed
Bachman KE, James GH, Paul GC, Adrian M, Joseph FC, Webster KC, Stephen BB, Jeremy RG (1999) Methylation-associated silencing of the tissue inhibitor of Metalloproteinase-3 gene suggests a suppressor role in kidney, brain, and other human cancers. Cancer Res 59:798–802PubMed
Bah PB, Mirkin JN, Oliver TK et al (2012) Benefits and harms of CT screening for lung cancer—a systematic review. JAMA 307(22):2418–2429CrossRef
Behrend L, Henderson G, Zwacka RM (2003) Reactive oxygen species in oncogenic transformation. Biochem Soc Trans 31(6):1441–1444PubMedCrossRef
Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, De Villers EM (2010) Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401(1):70–79PubMedPubMedCentralCrossRef
Bodaghi S, Wood LV, Roby G, Ryder C, Steinberg SM, Zheng ZM (2005) Could human papillomaviruses be spread through blood? J Clin Microbiol 43(11):5428–5434PubMedPubMedCentralCrossRef
Bodily J, Laimins LA (2011) Persistence of human papillomavirus infection: key to malignant progression. Trends Microbiol 19(1):33–39PubMedCrossRef
Bohlmeyer T, Le TN, Shroyer L, Markham N, Shtoyer KR (1998) Detection of Human Papillomavirus in Squamous Cell Carcinomas of the lung by Polymerase Chain Reaction. Am J Respir Cell Mol Biol 18:265–269PubMedCrossRef
Boyer SN, Wazer DE, Band V (1996) E7 protein of human papillomavirus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 56:4620–4624PubMed
Brambilla E, Negoescu A, Gazzeri S, Lantuejoul S, Moro D, Brambilla C, Coll JL (1996) Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors. Am J Pathol 149(6):1941PubMedPubMedCentral
Branica BV, Smojer-Jezek S, Juros Z, Grgic S, Srpak N, Mitrecic D, Gajovic S (2010) Detection of human papillomaviruses type 16, 18 and 33 in bronchial aspirates of lung carcinoma patients by polymerase chain reaction: a study of 84 cases in croatia. Coll Antropol 34(1):159–162PubMed
Brat DJ, Bellail AC, Van Meir EG (2005) The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro Oncol 7(2):122–133PubMedPubMedCentralCrossRef
Buonomo T, Carraresi Laura, Rossini Mara, Martinelli Rosanna (2011) Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins. J Transl Med 9(2):1–11
Burke L, Mohammed AK, Andrew NF et al (1998) Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer. Cancer Res 58:2533–2536PubMed
Butler D, Collins C, Mabruk M, Walsh CB, Leader MB, Kay EW (2000) Deletion of the FHIT gene in neoplastic and invasive cervical lesions is related to high-risk HPV infection but is independent of histopathological features. J Pathol 192:502–510PubMedCrossRef
Carpagnano GE, Koutelou A, Natalicchio MI, Martinelli D, Ruggieri C, Di Taranto A, Antonetti R, Carpagnano F, Foschino-Barbaro MP (2011) HPV in exhaled breath condensate of lung cancer patients. Br J Cancer 105:1183–1190PubMedPubMedCentralCrossRef
Castillo A, Aguayo F, Koriyama C, Shuyama K, Akiba S, Herrera-Goepfert R, Carrascal E, Klinge G, Sánchez J, Eizuru Y (2006) Human papillomavirus in lung carcinomas among three Latin American countries. Oncol Rep 15:883–888PubMed
Chao CH, Chen CM, Cheng PL, Shih JW, Tsou AP, Lee YHW (2006) DDX3, a dead box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor. Cancer Res 66(13):6579–6588PubMedCrossRef
Chen ACH, Keleher A, Kedda MA, Spurdle AB, McMillan NA, Antonsson A (2009) Human papillomavirus DNA detected in peripheral blood samples from healthy Australian male blood donors. J Med Virol 81(10):1792–1796PubMedCrossRef
Chen ZM, Peto R, Iona A et al (2015) Emerging tobacco-related cancer risks in China: a nationwide, prospective study of 0.5 million adults. Cancer 121(S17):3097–3106PubMedPubMedCentralCrossRef
Cheng YW, Chiou HL, Sheu GT et al (2001) The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res 61(7):2799–2803PubMed
Cheng YW, Wu MF, Wang J, Yeh KT, Goan YG, Chiou HL, Chen CY, Lee H (2007) Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation. Cancer Res 67:10686–10693PubMedCrossRef
Cheng YW, Lee H, Shiau MY, Wu TC, Huang TT, Chang YH (2008a) Human papillomavirus type 16/18 up-regulates the expression of interleukin-6 and antiapoptotic Mcl-1 in non-small cell lung cancer. Clin Cancer Res 14(15):4705–4712PubMedCrossRef
Cheng YW, Wu TC, Chen CY, Chou MC, Ko JL, Lee H (2008b) Human Telomerase Reverse Transcriptase Activated by E6 Oncoprotein Is Required for Human Papillomavirus-16/18-Infected Lung Tumorigenesis. Clin Cancer Res 14(22):7175–7179CrossRef
Chiou HL, Wu MF, Liaw YC, Cheng YW, Wong RH, Chen CY, Lee H (2003) The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan. Cancer 97(6):1558–1563PubMedCrossRef
Ciotti M, Giuliani L, Ambrogi V, Ronci C, Benedetto A, Mineo TC, Syrjänem K, Favalii C (2006) Detection and expression of human papillomavirus oncogenes in non-small cell lung câncer. Oncol Rep 16:183–189PubMed
Coissard CJ, Besson G, Polete MC, Monteau M, Birembaut PL, Clavel CE (2005) Prevalence of human papillomaviruses in lung carcinomas: a study of 218 cases. Mod Pathol 18:1606–1609PubMed
Dong SM, Pai SI, Rha SH, Hildesheim A, Kurman RJ, Schwartz PE, Mortel R, McGowan L, Greenberg MD, Barnes WA et al (2002) Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma. Cancer Epidemiol Biomark Prev 11(1):3–6
Doorbar J, Quint W, Banks L, Bravo IG, Stoler M, Broker TR, Stanley MA (2012) The biology and life-cycle of human papillomaviruses. Vaccine 30(Suppl 5):F55–F70PubMedCrossRef
Dyson N, Guida P, Munger K, Harlow E (1992) Homologous sequences in adenovirus E1 A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J Virol 66(1):6893–6902PubMedPubMedCentral
Elferink CJ, Ge NL, Levine A (2001) Maximal aryl hydrocarbon receptor activity depends on an interaction with the retinoblastoma protein. Mol Pharmacol 59(4):664–673PubMed
Finzer P, Kuntzen C, Soto U, zur Hausen H, Rösl F (2001) Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression. Oncogene 20(35):4768–4776PubMedCrossRef
Freije JMP, Milagros B, Alberto MP, Luis MS, Xose SP, Carlos LO (2003) Matrix metalloproteinases and tumor progression. Adv Med Biol 532:91–107CrossRef
Frolov MV, Dyson NJ (2004) Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J Cell Sci 117(11):2173–2181PubMedCrossRef
Ge NL, Elferink CJ (1998) A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein. J Biol Chem 273(35):22708–22713PubMedCrossRef
Giuliani L, Jaxmar T, Casadio C, Gariglio M, Manna A, D’Antonio D, Syrjanen K, Favalli C, Ciotti M (2007) Detection of oncogenic viruses (SV40, BKV, JCV, HCMV, HPV) and p53 codon 72 polymorphism in lung carcinoma. Lung Cancer 57(3):273–281PubMedCrossRef
Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP (1997) Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74(2):111–122PubMed
Goto A, Li CP, Ota S et al (2011) Human papillomavirus infection in lung and esophageal cancers: analysis of 485 Asian cases. J Med Virol 83(8):1383–1390PubMedCrossRef
Hadju SI (2006) A note from history: The link between koilocytes and human papillomaviruses. Ann Clin Lab Sci 36(4):485–487
Hensing T, Chawla A, Batra R, Salgia R (2014) A personalized treatment for lung cancer: molecular pathways, targeted therapies, and genomic characterization. In: Systems Analysis of Human Multigene Disorders. Springer, New York. pp 85–117
Hirayasu T, Iwamasa T, Kamada Y, Koyanagi Y, Usuda H, Genka K (1996) Human papillomavirus DNA in squamous cell carcinoma of the lung. J Clin Pathol 49(10):810–817PubMedPubMedCentralCrossRef
Hiroshima K, Toyozaki T, Iyoda A, Ohwada H, Kado S, Shirasawa H, Fujisawa T (1999) Ultrastructural study of intranuclear inclusion bodies of pulmonary adenocarcinoma. Ultrastruct Pathol 23(6):383–389PubMedCrossRef
Ho CM, Yang SS, Chien TY, Huang SH, Jeng CJ, Chang SF (2005) Detection and quantitation of human papillomavirus type 16, 18 and 52 DNA in the peripheral blood of cervical cancer patients. Gynecol Oncol 99(3):615–621PubMedCrossRef
Hollen PJ, Gralla RJ, Kris MG, Cox C, Belani CP, Grunberg SM, Crawford J, Neidhart JA (1995) Measurement of quality of life in patients with lung cancer in multicenter Trials of New Therapies. Cancer 73(8):2087–2098CrossRef
Hsu NY, Cheng YW, Chan IP, Ho HC, Chen CY, Hsu CP, Lin MH, Chou MC (2009) Association between expression of human papillomavirus 16/18 E6 oncoprotein and survival in patients with stage I non-small cell lung cancer. Oncol Rep 21(1):81–87PubMed
Huang HK, Joazeiro CAP, Bonfoco E, Kamada S, Leverson JD, Hunter T (2000) The inhibitor of apoptosis, ciap2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7. J Biol Chem 275(35):26661–26664PubMed
Huang Y, Huang MN, Li N, Li XG, Wu LY (2008) Association between human papillomavirus DNA load and development of cervical intraepithelial neoplasia and cervical cancer. Int J Gynecol Cancer 18:755–760PubMedCrossRef
Huibregtse JM, Scheffner M, Howley PM (1993) Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol Cell Biol 13(2):775–784PubMedPubMedCentralCrossRef
Jain N, Singh V, Hedau S, Kumar S, Daga MK, Dewan R, Murthy NS, Husain SA, Das BC (2005) Infection of human papillomavirus type 18 and p53 codon 72 polymorphism in lung cancer patients from India. Chest 128(6):3999–4007PubMedCrossRef
James MA, Lee JH, Klingelhutz AJ (2006) HPV16-E6 associated hTERT promoter acetylation is E6AP dependent, increased in later passage cells and enhanced by loss of p300. Int J Cancer 119:1878–1885PubMedPubMedCentralCrossRef
Joh J, Jenson AB, Moore GD, Rezazedeh A, Slone SP, Ghim SJ, Kloecker GH (2010) Human papillomavirus (HPV) and Merkel cell polyomavirus (MCPyV) in non small cell lung cancer. Exp Mol Pathol 89(3):222–226PubMedCrossRef
Kashima H, Mounts P, Leventhal B, Hruban RH (1993) Sites of predilection in recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 102:580–583PubMedCrossRef
Kato T, Loriyama C, Khan N, Samukawa T, Yanagi M, Hamada T, Yokomakura N, Otsuka T, Inoue H, Sato M, Natsugoe S, Akiba S (2012) EGFR mutations and human papillomavirus in lung cancer. Lung Cancer 78:144–147PubMedCrossRef
Kinoshita I, Dosaka-Akita H, Shindoh M, Fujino M, Akie K, Kato M, Fujinaga K, Kawakami Y (1995) Human papillomavirus type 18 DNA and E6-E7 mRNA are detected in squamous cell carcinoma and adenocarcinoma of the lung. Br J Cancer 71(2):344PubMedPubMedCentralCrossRef
Koshiol J, Rotunno M, Gillison ML et al (2011) Assessment of human papillomavirus in lung tumor tissue. J Nati Cancer Inst 103(6):501–507CrossRef
Koutsodontis G, Tentes I, Papakosta P, Moustakas A, Kardassis D (2001) Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21WAF1/Cip1 gene by the p53 tumor suppressor protein. J Biol Chem 276(31):29116–29125PubMedCrossRef
Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC (1993) Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 53:4701–4714PubMed
Kulski JK, Demeter T, Mutavdzic S, Sterrett GF, Mitchell KM, Pixley EC (1990) Survey of histologic specimens of human cancer for human papillomavirus types 6/11/16/18 by filter in situ hybridization. Am J Clin Pathol 94(5):566–570PubMedCrossRef
Kyo S, Takakura M, Fujiwara T et al (2008) Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Cancer Sci 99:1528–1538PubMedCrossRef
Li G, He L, Zhang E, Shi J, Zhang Q, Le AD, Zhou K, Tang X (2011) Overexpression of human papillomavirus (HPV) type 16 oncoproteins promotes angiogenesis via enhancing HIF-1a and VEGF expression in non-small cell lung cancer cells. Cancer Lett 311:160–170PubMedCrossRef
Liu VW, Tsang P, Yip A, Ng TY, Wong LC, Ngan HY (2001) Low incidence of HPV DNA in sera of pretreatment cervical cancer patients. Gynecol Oncol 82(2):269–272PubMedCrossRef
Liu X, Yuan H, Fu B, Disbrow GL, Apolinario T, Tomaić V, Kelley ML, Baker CC, Huibregtse J, Schlegel R (2005) The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein. J Biol Chem 280(11):10807–10816PubMedCrossRef
Major T, Szarka K, Sziklai I, Gergely L, Czeglédy J (2005) The characteristics of human papillomavirus DNA in head and neck cancers and papillomas. J Clin Pathol 58(1):51–55PubMedPubMedCentralCrossRef
Mehra R, Egleston B, Yang D, Scott W, Borghaei H, Ragin C (2013) A pilot study of the association and prevalence of the human papillomavirus (HPV) in non-small cell lung cancer (NSCLC). Cancer Res 73:4785CrossRef
Miyagi J, Tsuhako K, Kinjo T, Iwamasa T, Hirayasu T (2000) Recent striking changes in histological differentiation and rate of human papillomavirus infection in squamous cell carcinoma of the lung in Okinawa, a subtropical island in southern Japan. J Clin Pathol 53(9):676–684PubMedPubMedCentralCrossRef
Mork J, Lie KL, Glattre E, Clark S, Phill D, Hallmans G, Jellum E, Koskela P, Moller B, Pukkala E, Schiller JT, Wang Z, Youngman L, Lehtinem M, Dilner J (2001) Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344:1125–1131PubMedCrossRef
Nadji SA, Azad TM, Mahmoodi M, Yahyapour Y, Naghshvar F, Torabizadeh J, Ziaee AA, Nategh R (2007) Relationship between lung cancer and human papillomavirus in north of Iran, Mazandaran province. Cancer Lett 248:41–46PubMedCrossRef
Nuorva K, Soini Y, Kamel D, Pöllänen R, Bloigu R, Vähäkangas K, Pääkkö P (1995) p53 protein accumulation and the presence of human papillomavirus dna in bronchiolo-alveolar carcinoma correlate with poor prognosis. Int J Cancer 64(6):424–429PubMedCrossRef
Pao CC, Lin SS, Lin CY, Maa JS, Lai CH, Hsieh TT (1991) Identification of human papillomavirus DNA sequences in peripheral blood mononuclear cells. Am J Clin Pathol 95(4):540–546PubMedCrossRef
Pao CC, Hor JJ, Yang FP, Lin CY, Tseng CJ (1997) Detection of human papillomavirus mRNA and cervical cancer cells in peripheral blood of cervical cancer patients with metastasis. J clin oncol 15(3):1008–1012PubMed
Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74–108PubMedCrossRef
Peña N, Carrillo D, Muñoz JP, Chnaiderman J, Urzúa U, León O, Tornesello ML, Corvalán AH, Soto-Rifo R, Aguayo F (2015) Tobacco smoke activates human papillomavirus 16 p97 promoter and cooperates with high-risk e6/e7 for oxidative dna damage in lung cells. PLoS One 10(4):e0123029PubMedPubMedCentralCrossRef
Rubel L, Reynolds RE (1979) Cytologic description of squamous cell papilloma of the respiratory tract. Acta Cytol 23(3):227–231PubMed
Samet JM (1991) Health benefits of smoking cessation. Clin Chest Med 12:669–679PubMed
Sarchianaki E, Derdas SP, Ntaoukakis M et al (2014) Detection and genotype analysis of human papillomavirus in non-small cell lung cancer patients. Tumor Biol 35:3203–3209CrossRef
Schamberger AC, Staab-Weijnitz CA, Mise-Racek N, Eickelberg O (2015) Cigarette smoke alters primary human bronchial epithelial cell differentiation at the air-liquid interface. Scientific reports, 5
Shiau MY, Fan LC, Yang SC, Tsao CH, Lee H, Cheng YW, Lai LC, Chang YH (2013) Human papillomavirus up-regulates MMP-2 and MMP-9 expression and activity by inducing interleukin-8 in lung adenocarcinomas. PLoS One 8(1):e54423PubMedPubMedCentralCrossRef
Shih CM, Lee YL, Chiou HL, Hsua WF, Chen WE, Chou MC, Lin LY (2005) The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer. Lung Cancer 50:291–297PubMedCrossRef
Silverman DT, Samanic CM, Lubin JH et al (2012) The Diesel Exhaust in Miners Study: A Nested Case-Control Study of Lung Cancer and Diesel Exhaust. J Natl Cancer Inst 104:1–14
Smith EM, Ritchie JM, Summersgill KF, Klussmann JP, Lee JH, Wang D, Haugen TH, Turek LP (2004) Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 108:766–772PubMedCrossRef
Sozzi G, Sozi G, Pastorino U et al (1998) Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res 58:5032–5037PubMed
Steenbergen RD, de Wild J, Wilting SM et al (2005) HPV-mediated transformation of the anogenital tract. J Clin Virol 32:S25–S33PubMedCrossRef
Sun S, Schiller JH, Gazdar AF (2007) Lung cancer in never smokers-a different disease. Nature 7:778–790
Sung WW, Wang YC, Lin PL, Cheng YW, Chen CY, Wu TC, Lee H (2013) IL-10 promotes tumor aggressiveness via upregulation of cip2a transcription in lung adenocarcinoma. Clin Cancer Res 19(15):4092–4103PubMedCrossRef
Syrjänen KJ (1979) condylomatous changes in neoplastic bronchial epithelium. Respiration 38:299–304PubMedCrossRef
Syrjänen KJ (1980) Epithelial lesions suggestive of a condylomatous origin found closely associated with invasive bronchial squamous cell carcinomas. Respiration 40(3):150–160PubMedCrossRef
Syrjänen S (2005) Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 32:59–66CrossRef
Syrjänen K (2012) Detection of human papillomavirus in lung cancer: systematic review and meta-analysis. Anticancer Res 32(8):3235–3250PubMed
Syrjänen K, Syrjänen S, Kellokoski J, Kärjä J, Mäntyjärvi R (1989) Human papillomavirus (HPV) type 6 and 16 DNA sequences in bronchial squamous cell carcinomas demonstrated by in situ DNA hybridization. Lung 167(1):33–42PubMedCrossRef
Thorland EC, Myers SL, Persing DH, Sarkar G, McGovern RM, Gostout BS, Smith DI (2000) Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. Cancer Res 60:5916–5921PubMed
Torok S, Hegedus B, Laszlo V, Hoda MA, Ghanim B, Berger W, Klepetko W, Dome B, Ostoros G (2011) Lung cancer in never smokers. Future Oncol 7(10):1195–1211PubMedCrossRef
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108PubMedCrossRef
Tsai HJ, Peng YW, Lin LY, Chou MC, Lee H, Chiou HL (2005) An association between human papillomavirus 16/18 deoxyribonucleic acid in peripheral blood with p16 protein expression in neoplastic cervical lesions. Cancer Detect Prev 29(6):537–543PubMedCrossRef
Tsuhako K, Nakazato I, Hirayasu T, Sunakawa H, Iwamasa T (1998) Human papillomavirus DNA in adenosquamous carcinoma of the lung. J Clin Pathol 51(10):741–749PubMedPubMedCentralCrossRef
Tung MC, Wu HH, Cheng YW, Wang L, Chen CY, Yeh SD, Wu TC, Lee H (2013) Association of epidermal growth factor receptor mutations with human papillomavirus 16/18 E6 oncoprotein expression in non-small cell lung cancer. Cancer 119(18):3367–3376PubMedCrossRef
Turek LP, Smith EM (1996) The genetic program of genital human papillomaviruses in infection and cancer. Obstet Gynecol Clin 23(4):735–758CrossRef
Wang T, Zeng X, Li W, Zhu H, Wang G, Liu X, Lv Y, Wu J, Zhuang X, Zhang J et al (2014) Detection and analysis of human papillomavirus (HPV) DNA in breast cancer patients by an effective method of HPV capture. PLoS One 9(3):e90343PubMedPubMedCentralCrossRef
Whitlock JP Jr (1999) Induction of cytochrome P4501A1. Ann Rev Pharmacol Toxicol 39:103–125CrossRef
Wilson EB, Brooks DG (2011) The role of IL-10 in regulating immunity to persistent viral infections. Curr Top Microbiol Immunol 350:39–65PubMedPubMedCentral
Wu EW, Clemens KE, Heck DV, Munger K (1993) The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein. J Virol 67(4):2402–2407PubMedPubMedCentral
Wu MF, Cheng YW, Lai JC, Hsu MC, Chen JT, Liu WS, Chiou MC, Chen CY, Lee H (2005) Frequent p16INK4a promoter hypermethylation in human papillomavirus-infected female lung cancer in Taiwan. Int J Cancer 113:440–445PubMedCrossRef
Wu Y, Chen Y, Li L, Yu G, Zhang Y, He Y (2006) Association of high-risk HPV types and viral load with cervical câncer in China. J Clin Virol 35:264–269PubMedCrossRef
Wu M, Min C, Wang X, Yu Z, Kirsch KH, Trackman PC, Sonenshein GE (2007) Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells. Cancer Res 67(13):6278–6285PubMedCrossRef
Wu HH, Wu JY, Cheng YW, Chen CY, Lee MC, Goan YG, Lee H (2010) cIAP2 upregulated by E6 oncoprotein via epidermal growth factor receptor/phosphatidylinositol 3-kinase/AKT pathway confers resistance to cisplatin in human papillomavirus 16/18–infected lung cancer. Clin Cancer Res 16(21):5200–5210PubMedCrossRef
Wu DW, Tsai LH, Chen PM et al (2011) Reduced p21WAF1/CIP1 via alteration of p53-DDX3 pathway is associated with poor relapse-free survival in early-stage human papillomavirus-associated lung cancer. Clin Cancer Res 17:1895–1905PubMedCrossRef
Wu DW, Tsai LH, Chen PM et al (2012) Loss of TIMP-3 promotes tumor invasion via elevated IL-6 production and predicts poor survival and relapse in HPV-infected non-small cell lung cancer. Am J Pathol 181(5):1796–1806PubMedCrossRef
Xu Y, Cheng B, Pan H, Wu A, Zhang L (2009) The relationship between the status of human papillomavirus 16/18 infection and the expression of Bcl-2 and bax in squamous cell carcinomas of the lung. Chin J Lung 12(8):849–852
Xue X, Zhihua Y, Lu Y et al (2013) The joint effect of hOGG1, APE1, and ADPRT polymorphisms and cooking oil fumes on the risk of lung adenocarcinoma in chinese non-smoking females. PLoS One 8(8):e71157PubMedPubMedCentralCrossRef
Yanagawa N, Wang A, Kohler D, Santos GC, Sykes J, Xu J, Pintilie M, Tsao MS (2013) Human papilloma virus genome is rare in North American non-small cell lung carcinoma patients. Lung Cancer 79(3):215–220PubMedCrossRef
Yano T, Miura N, Takenaka T et al (2008) Never-smoking nonsmall cell lung cancer as a separate entity: clinicopathologic feature and survival. Cancer 113:1012–1018PubMedCrossRef
Yohena T, Yoshino I, Takenaka T, Kameyama T, Ohba T, Kuniyoshi Y, Maehara Y (2009) Upregulation of hypoxia-inducible factor-1α mRNA and its clinical significance in non-small cell lung cancer. J Thorac Oncol 4(3):284–290PubMedCrossRef
Yu Y, Yang A, Hu S, Yan H (2009) Correlation of HPV-16/18 infection of human papillomavirus with lung squamous cell carcinomas in Western China. Oncol Rep 21(6):1627–1632PubMed
Yu YH, Liao CC, Hsu WH et al (2011) Increased lung cancer risk among patients with pulmonary tuberculosis: a population cohort study. J Thorac Oncol 6(1):32–37PubMedCrossRef
Yuan A, Yu CJ, Chen WJ, Lin FY, Kuo SH, Luh KT, Yang PC (2000) Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer. Int J Cancer 89(6):475–483PubMedCrossRef
Zhang E, Feng X, Liu F, Zhang P, Liang J, Tang X (2014) Roles of PI3K/Akt and c-Jun signaling pathways in human papillomavirus type 16 oncoprotein-induced HIF-1α, VEGF, and IL-8 expression and in vitro angiogenesis in non-small cell lung cancer cells. PLoS One 9(7):e103440PubMedPubMedCentralCrossRef
Zur Hausen H (2000) Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92(9):690–698PubMedCrossRef
Metadata
Title
Human papillomavirus and lung cancinogenesis: an overview
Authors
Antonio Carlos de Freitas
Ana Pavla Gurgel
Elyda Golçalves de Lima
Bianca de França São Marcos
Carolina Maria Medeiros do Amaral
Publication date
01-12-2016
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 12/2016
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-016-2197-1

Other articles of this Issue 12/2016

Journal of Cancer Research and Clinical Oncology 12/2016 Go to the issue

Original Article – Clinical Oncology

Which factors affect the long-term survival of patients with hepatocellular carcinoma UICC stage IV?

Original Article – Clinical Oncology

Comparison of two dose levels of cyclophosphamide for successful stem cell mobilization in myeloma patients

Original Article – Cancer Research

Suppression of GLI sensitizes medulloblastoma cells to mitochondria-mediated apoptosis

Original Article – Clinical Oncology

Acinar cell carcinoma of the pancreas: a rare disease with different diagnostic and therapeutic implications than ductal adenocarcinoma

Review – Clinical Oncology

Endometrial sampling devices for early diagnosis of endometrial lesions

Original Article – Cancer Research

Cytokeratin 18 knockdown decreases cell migration and increases chemosensitivity in non-small cell lung cancer
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits